{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01464",
      "entity_text" : "257-264  peptide",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:CD8",
      "entity_text" : "CD8",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Like CD8 + T cells that were activated in vitro using OVA 257-264 peptide and IL-2, OT-I CD8 + T cells that were activated using these in vivo methods were also capable of expressing CD40L upon peptide stimulation.",
  "reading_complete" : "2020-08-04T10:32:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T10:30:30Z",
  "trigger" : "activated",
  "evidence" : [ "CD8 +  T cells that were activated in vitro using OVA 257-264  peptide" ],
  "pmc_id" : "5672143",
  "score" : 0
}